Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE). by Plichart, Matthieu et al.
Parental smoking, maternal alcohol, coffee and tea
consumption during pregnancy and childhood malignant
central nervous system tumours: the ESCALE study
(SFCE).
Matthieu Plichart, Florence Menegaux, Brigitte Lacour, Olivier Hartmann,
Didier Frappaz, Franc¸ois Doz, Anne-Isabelle Bertozzi, Anne-Sophie
Defaschelles, Alain Pierre-Kahn, Ce´line Icher, et al.
To cite this version:
Matthieu Plichart, Florence Menegaux, Brigitte Lacour, Olivier Hartmann, Didier Frappaz,
et al.. Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and
childhood malignant central nervous system tumours: the ESCALE study (SFCE).. Euro-




Submitted on 21 Aug 2009
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy 
and childhood malignant central nervous system tumours: the ESCALE study (SFCE*) 
 
Short Title: Smoking, alcohol, coffee, tea and childhood CNS tumours 
 
 
Matthieu Plichart1,2, Florence Menegaux1,2, Brigitte Lacour1,2,3, Olivier Hartmann4, Didier 
Frappaz5, François Doz6, Anne-Isabelle Bertozzi7, Anne-Sophie Defaschelles8, Alain Pierre-
Kahn9, Céline Icher10, Pascal Chastagner11, Dominique Plantaz12, Xavier Rialland13, Denis 
Hémon1,2, Jacqueline Clavel1,2,14
 
1INSERM, U754, Villejuif, France. 2Univ Paris-Sud, UMR-S754, IFR69, Villejuif, 
france3Registre National des Tumeurs solides de l’Enfant, Nancy, France. 4Institut Gustave 
Roussy, Villejuif, France. 5Centre Léon Bérard, Lyon, France. 6Institut Curie, Paris, France. 
7Hôpital des Enfants, Toulouse, France. 8Centre Oscar Lambret, Lille, France. 9Hôpital des 
Enfants Malades, Paris, France. 10Hôpital Pellegrin Tripode, Bordeaux, France. 11Hôpital 
d’Enfants, Vandoeuvre les Nancy, France. 12Service de Pédiatrie, Grenoble, France. 13CHU 
D’Angers, France. 13Registre National des Hémopathies Malignes de l’Enfant 
*SFCE: Société Française de lutte contre les Cancers de l’Enfant et de l’Adolescent 
 
This work was supported by grants from INSERM, the Fondation de France, the Association 
pour la Recherche contre le Cancer (ARC), the Agence Française de Sécurité Sanitaire des 
Produits de Santé (AFSSAPS), the Agence Française de Sécurité Sanitaire de 




Dr. Florence Menegaux 
INSERM U754 
16, av. Paul Vaillant-Couturier 
F-94807 VILLEJUIF Cedex 
Tel: 33 1 45 59 51 53 
Fax: 33 1 45 59 51 91 
E-mail: menegaux@vjf.inserm.fr 
 
This is a non-final version of an article published in final form in Eur J Cancer Prev. 2008 
Aug;17(4):376-83.  
Abstract 
Objectives: Parental smoking and maternal alcohol and caffeinated beverage consumption 
are prevalent exposures which may play a role, either directly or through their influence on 
metabolism, in the aetiology of childhood malignant Central Nervous System (CNS) tumours. 
The hypothesis was investigated in the ESCALE study, a national population-based case-
control study carried out in France in 2003-2004.  
Methods: The study included 209 incident cases of CNS tumours and 1681 population-based 
controls, frequency matched with the cases by age and gender. The data were collected 
through a standardized telephone interview of the biological mothers.  
Results: No association between maternal smoking during pregnancy and CNS tumours (OR 
= 1.1 [0.8-1.6]) was observed. Paternal smoking during the year prior to birth was associated 
with CNS tumours (p for trend = 0.04), particularly astrocytomas (OR = 3.1 [1.3-7.6]). 
Maternal alcohol consumption during pregnancy was not associated with CNS tumours. 
Associations between ependymomas and the highest consumption of coffee (OR = 2.7 [0.9-
8.1]) and tea (OR = 2.5 [1.1-5.9]) were observed. A strong association between CNS 
tumours and the highest maternal consumption of both coffee and tea during pregnancy was 
observed (OR = 4.4 [1.5-13]).  
Conclusions: The results constitute additional evidence for a role of paternal smoking and 
suggest that maternal coffee and tea consumption during pregnancy may also increase the 
risk of CNS tumours. The study does not suggest an increased risk of CNS tumours related 
to alcohol consumption during pregnancy.  
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Introduction 
Central nervous system (CNS) tumours are the second most common pediatric cancer in 
developed countries. In France, the annual incidence rate is 29.1 per million children, 
equivalent to about 350 new cases per year (Desandes et al., 2004). Except for ionizing 
radiation and a few rare genetic factors, the aetiology of CNS tumours remains largely 
unknown (Baldwin and Preston-Martin, 2004). The central nervous system is more 
vulnerable to carcinogens early in life and the relatively young age at onset suggests that 
prenatal and early post-natal exposures may be considered potential risk factors (Rice and 
Wilbourn, 2000). Pre-conception exposure of germ cells to carcinogens, especially in the 
father, is also suspected of being related to an excess of tumours in the offspring (Anderson 
et al., 2000). The influence of exposure to tobacco smoke on the risk of CNS tumours has 
been investigated in numerous studies and a recent review has summarized the 
epidemiologic evidence (Baldwin and Preston-Martin, 2004). While no or a limited 
association has been found with maternal smoking during pregnancy, there is some 
evidence for an association between CNS tumours and pre-conception paternal smoking. 
Maternal alcohol and caffeinated beverage consumption during pregnancy have been shown 
to be associated with other childhood cancers, especially childhood leukaemia (Severson et 
al., 1993 ; Van Duijn et al., 1994 ; Shu et al., 1996 ; Ross et al., 1998 ; Menegaux et al., 
2005 ; Menegaux et al., 2007). For childhood CNS tumour, those factors have been less 
investigated. No consistent association with maternal alcohol drinking during pregnancy has 
been detected for childhood CNS tumours (Little, 1999). However, two studies reported a link 
with maternal beer drinking during pregnancy (Howe et al., 1989 ; Bunin et al., 1993), 
supporting the hypothesis that N-nitroso compounds play a role. To the authors' knowledge, 
only two studies have investigated the role of maternal caffeinated beverage consumption 
during pregnancy with respect to childhood CNS tumours (Bunin et al., 1993 ; Bunin et al., 
1994 ; Cordier et al., 1994). Neither reported a significant association. 
The present paper analyzes the role of parental tobacco smoking and maternal alcohol and 
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caffeinated beverage consumption during pregnancy with respect to childhood CNS tumours 
using data generated by the ESCALE study. The latter investigated the role of environmental 
and genetic factors with regard to the 4 most frequent types of childhood cancers: 
leukaemias, lymphomas, CNS tumours and neuroblastomas. 
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Patients and methods 
Study population 
Cases 
Details of the study have been published elsewhere (Rudant et al., 2007). For the present 
analysis, the eligible cases comprised all children aged less than 15 years, residing in 
mainland France at the time of diagnosis of a primary malignant CNS tumour in 2003-2004. 
The tumours were defined as per the International Classification of Diseases for Oncology, 
third version (ICD-O-3). Investigators, assigned to each French pediatric oncology hospital 
department, directly recruited CNS tumour cases with the support of the French National 
Registry of Childhood Haematopoietic Malignancies (NRCH) (Clavel et al., 2004) and the 
French National Registry of Childhood Solid Tumours (NRCST) (NRCST website). Adopted 
children (5 cases) and children whose mother did not speak French (14 cases) or had a 
serious psychiatric disorder (5 cases) were not eligible. For ethical reasons, children who had 
died or were receiving palliative care before the inclusion date (58 cases) were not eligible 
either. Out of the 343 cases identified, 261 were eligible, 19 of them refused to participate 
and 33 could not be contacted by the interviewers. Thus, 209 (80%) incident cases classified 
as malignant CNS tumours (/3 behaviour) according to ICD-O-3 were included and grouped 
using the International Classification of Childhood Cancer (Steliarova-Foucher et al., 2005). 
The cases consisted of 100 cases (48%) of embryonal tumour (ICD-O-3 codes 9470/3, 
9471/3, 9473/3, 9474/3, 9480/3, 9508/3), 33 cases (16%) of ependymoma (9390/3-9393/3), 
26 cases (12%) of astrocytoma (9380/3, 9400/3, 9420/3, 9424/3, 9440/3) and 45 cases 
(21%) of other glioma (9380/3, 9382/3, 9430/3, 9450/3, 9451/3). The remaining cases were 
distributed as follows: 3 (2%) not otherwise specified tumours and 2 (1%) otherwise specified 
tumours. 
Controls 
A random sample of French children (up to age 14 years) was obtained from a 
representative list of 60,000 addresses provided by the French national telephone company, 
enriched by random generation of unlisted phone numbers. Quotas were designed a priori to 
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make the control group representative of, first, all cases of childhood cancer (leukaemia, 
lymphoma, neuroblastoma and central nervous system tumour) in terms of age and gender, 
and, secondly, the French population with regard to the number of children under 15 years of 
age living in the household.  Out of the 50,217 phone numbers dialed, 46,994 were non-
eligible numbers (22,584 businesses or inactive numbers, 18,456 households without 
children, 5,277 outside of the quotas, 677 unreliable interviews). The eligibility of 862 phone 
numbers could not be determined. Finally, out of the 2361 children who were eligible as 
controls, 1681 (71%) were included in the study (679 parents refused and 1 child had a prior 
history of neuroblastoma). 
Data collection 
Trained interviewers conducted telephone interviews with the biological mothers of the cases 
and controls. The mean interview duration was 40 minutes. The standardized questionnaire 
sought information on demographic and socioeconomic characteristics, parental occupa-
tional history, parental lifestyle, family and personal medical history, history of pregnancy and 
childhood environment. The present study particularly focused on parental tobacco smoking 
and maternal alcohol and caffeinated beverage consumption. Mothers were asked whether 
they had ever smoked or drunk alcohol, coffee, tea, chocolate or cola during pregnancy. If 
so, further questions were asked to elicit the daily or weekly amount consumed, for each of 
the items. The period of interest for paternal smoking was the year prior to the index child’s 
birth. 
Statistical analyses 
The SAS® software package (version 9.1, Cary, North Carolina) was used for all the 
analyses. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated by non-
conditional logistic regression for all CNS tumours, with systematic adjustment for the 
stratification variables, age and gender. Adjustment for potential confounding factors, such 
as the place of residence at the time of diagnosis, maternal and paternal educational level 
and socioeconomic category, was also conducted. The countries of birth of the 4 grand-
parents were used as surrogates of ethnic origin (Europe, Africa / the Caribbean, Asia, North 
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Africa, mixed). Analyses of tumour histologic subgroups were conducted using polytomous 
regression models.  
Results 
Sample description 
The cases and controls did not differ with respect to gender (Table 1). Since the age quotas 
for control selection had been defined so as to be representative of all types of cancer and 
not only of CNS cases, there was a small age discrepancy between the CNS cases and 
controls. However, the mean ages of the cases and controls were very similar (6.3 vs 6.0 
years). There were at least 5 controls for each case in each age group. No significant 
difference between the cases and controls was observed with respect to parental educational 
level or socioeconomic category.  
Parental smoking 
No association between maternal smoking during pregnancy and CNS tumours in the 
children was detected (OR = 1.1 [0.8-1.6]). No association or trend with the number of 
cigarettes smoked per day was observed (Table 2).  
Paternal smoking was associated with CNS tumours, and the ORs increased with the 
number of cigarettes smoked (< 20 cig/day: OR = 1.1 [0.8-1.6]; ≥ 20 cig/day: OR = 1.4 [1.0-
2.1] ; p for trend = 0.04). When both the mother's and the father's smoking was considered, the 
OR was 1.3 [1.0-1.9] for only the father smoking, 1.6 [0.9-3.0] for only the mother smoking, 
and 1.2 [0.7-1.8] for both parents smoking. 
None of the histological subgroups was significantly associated with maternal smoking during 
pregnancy, whereas paternal smoking of more than 20 cigarettes per day during the year 
prior to pregnancy was associated with astrocytoma (OR = 3.2 [1.2-9.1]) and ependymoma 
(OR = 2.6 [1.2-5.9]) (Table 3). In contrast, neither embryonal tumors nor other gliomas 
appeared to be linked to paternal smoking. 
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Maternal consumption of coffee and tea 
There was no association between CNS tumours taken as a whole and consumption of 
caffeinated beverages by the mother during pregnancy (table 4). Slightly, but not 
significantly, increased ORs were associated with the highest consumptions of coffee (OR = 
1.4 [0.8-2.4]) and tea (OR = 1.4 [0.9-2.1]). Higher ORs were observed for ependymoma, but 
the number of cases was small. The associations were more marked for the highest maternal 
consumptions of both coffee (>3 cups per day) and tea (>1 cup per day).  Adjustment for 
maternal and paternal smoking did not change the results. 
Maternal alcohol consumption during pregnancy 
No association between CNS tumors and maternal consumption of any kind of alcohol during 
pregnancy was detected (OR = 0.9 [0.7-1.3]) (Table 5).  
The results remained unchanged after adjusting for parental educational level and 
socioeconomic category.  
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Discussion 
In this study, paternal smoking during the year prior to pregnancy was associated with CNS 
tumours, and the association was more pronounced for astrocytoma. On the whole, there 
was no significant association with maternal smoking during pregnancy, although a 
borderline association with maternal smoking in the absence of paternal smoking was found. 
Maternal alcohol consumption during pregnancy was not associated with childhood CNS 
tumours, while maternal coffee and tea consumption during pregnancy were significantly 
associated with CNS tumours and particularly with ependymomas.  
The size of the present study enabled detection of minimum odds ratios of 1.5 and 1.6 for 
exposure prevalence in controls of 30 and 20%, respectively, i.e. of the same order of 
magnitude as those of maternal alcohol drinking during pregnancy or parental smoking. 
The cases were identified through the data collection system of the French National 
Registries of Childhood Cancer (NRCH, NRCST), making selection of cases at the 
identification step unlikely. Cases who had died or were receiving palliative care were not 
eligible, which might have lead to survival bias. Nevertheless, we were able to compare the 
prevalence of parental smoking of 19 cases that died after their mothers' interviews with the 
prevalence of parental smoking of the survivors. The prevalence of parental smoking, either 
for maternal and paternal smoking, did not differ between the non-surviving and surviving 
children making a survival bias unlikely in the present study. 
Eighteen percent of the eligible cases did not answer the questionnaire. However, the age 
and gender distributions were similar for the respondent and non-respondent cases. 
 
The controls were randomly selected from the general population, based on the national 
telephone directory. Unlisted numbers were randomly generated in order to avoid the 
selection of controls with listed numbers. 
There were no differences between the cases and controls with regard to gender or age 
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(considering all the types of cancer covered by the ESCALE study), or between the controls 
and overall population, particularly with regard to birth order, number of children living in the 
household and socio-demographic characteristics, indicating that quota sampling was 
successful. The socioeconomic status and educational level of the control parents were very 
similar to those of the cases and the French population (Blondel et al., 1997 ; Blondel et al., 
2006). Adjustments for those variables did not change the results. Additional adjusment for 
ethnic origin (countries of birth of the 4 grand-parents) of the index child did not change the 
results as well. 
All the information was based on the child’s mother’s interview. The mothers could have 
misreported their smoking habits and those of the father. However, the number of cigarettes 
smoked by the control mothers was comparable to that of the French population (Blondel et 
al., 1997 ; Blondel et al., 2006), as was the number smoked by the control fathers (Guilbert P 
et al., 2005). The results are therefore unlikely to be explained by under-reporting of smoking 
by the controls. In addition, the case mothers may have under-reported their own smoking, 
leading to under-estimation of the association with maternal smoking. However, the results 
reported herein are consistent with 2 meta-analyses that found no association between CNS 
tumours and maternal smoking during pregnancy (Boffetta et al., 2000 ; Huncharek et al., 
2002). One recent cohort study (Brooks et al., 2004) reported a significantly increased risk 
related to maternal smoking, but this association was found to be significant for low grade 
astrocytomas, which were not eligible in the present study, and not for malignant brain 
tumours. However, an association with maternal smoking during pregnancy cannot be 
completely ruled out, given the slightly increased OR with maternal smoking in the absence 
of paternal smoking observed herein.  
Case mothers may have over-reported smoking by the father, which would explain the 
relationship with paternal smoking. However, the paternal smoking habits of the controls 
were very similar to those of the French population (Guilbert P et al., 2005). Moreover, 
several previous studies, that investigated paternal smoking by interviewing the father 
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himself also found positive associations (McCredie et al., 1994 ; Ji et al., 1997 ; Fillipini et al., 
2002 ; Cordier et al., 2004). Two meta-analyses estimated ORs of 1.22 [1.05-1.40] and 1.29 
[1.07-1.53] for paternal smoking during pregnancy (Boffetta et al., 2000 ; Huncharek et al., 
2001 ; respectively). Cordier et al. reported an increased risk of malignant astrocytoma 
among children whose father was exposed to PAH from smoking, before the conception 
(Cordier et al., 2004). In the study by McCredie et al., malignant brain tumours were 
associated with pre-conception paternal smoking and maternal exposure to side-stream 
smoke from the father during pregnancy (McCredie et al., 1994). Two biologically-plausible 
mechanisms have been proposed to explain those findings. A direct hypothesis, supported 
by both animal and human data (Baldwin and Preston-Martin, 2004), suggests an impact of 
pre-conception paternal germ-cell exposure. Spermatogenesis is a continuous process, with 
intense replication of DNA, making germ cells more vulnerable to mutagenic changes 
(Anderson et al., 2000). The second hypothesis suggests that paternal smoking may act 
through the mother’s passive exposure to side-stream smoke during pregnancy. Biochemical 
studies showed that some constituents of environmental tobacco smoke may cross the 
placenta and interact with fetal DNA (Tredaniel et al., 1994 ; Anderson et al., 2000 ; Rice, 
2004). However, the epidemiological data on this question are contradictory. Among the 
studies that explicitly addressed the role of passive exposure to tobacco smoke, some 
evidenced an association between CNS tumor and maternal exposure to side-stream smoke 
(Preston-Martin et al., 1982 ; McCredie et al., 1994 ; Filippini et al., 2002)  while as many 
others did not (Kuijten et al., 1990 ; Cordier et al., 1994 ; Hu et al., 2000) . It is noteworthy 
that paternal smoking remains difficult to differentiate from maternal smoking. Similarly, there 
are strong correlations between pre-conception, gestational and post-natal maternal and 
paternal smoking that make it difficult to elucidate the actual exposure with certainty in the 
context of paternal pre-conception smoking. However, the literature has not reported any 
evidence of an association with passive smoking during childhood (Ji et al., 1997 ; Little, 
1999 ; Filippini et al., 2002).  
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The present study did not generate any evidence of an association between alcohol 
consumption during pregnancy and malignant CNS tumours. Alcohol consumption is difficult 
to quantify by questionnaires, and an information bias may have occurred, even though its 
extent would have been reduced by the use of a detailed standardized questionnaire. Guilt 
feelings may have led the cases' mothers to minimize their alcohol consumption during 
pregnancy and the resulting recall bias may have masked an association. However, the bias 
is more likely to affect the dose-response relationship than the ever/never relationship. The 
literature on maternal alcohol drinking during pregnancy and CNS tumours is very limited and 
shows no consistent association. However, two studies evidenced that beer drinking during 
pregnancy was associated with CNS tumours (Howe et al., 1989) or with primitive 
neuroectodermal tumours (PNET) (Bunin et al., 1993). Beer is a known source of N-nitroso 
compounds (NOC), which are suspected to play a role in childhood brain tumours. In the 
present study, beer consumption was slightly, but not significantly, related to CNS tumours 
and particularly to PNET and other gliomas.  
The results for maternal coffee and tea consumption raise some questions. A recall bias is 
unlikely given that there is no particular public concern with those habits. Wilkins et al. 
reported no differences between cases and controls for mothers recalling their own diet in a 
case-control study on childhood brain tumours (Wilkins and Bunn, 1997). Furthermore, 
associations with maternal consumption of coffee and tea during pregnancy were limited to 
ependymomas, which makes bias less likely. Cordier et al. found an increased OR 
associated with coffee (1.9 [0.9-3.9]), but nor with tea (0.7 [0.3-1.4]) (Cordier et al., 1994).  
In conclusion, the findings reported herein constitute additional evidence for a role of paternal 
smoking during the year prior to birth in childhood CNS tumours. The results also suggest 
that maternal coffee and tea consumption may increase the risk of CNS tumours, directly or 
through an influence on the metabolism of unknown risk factors. Further investigations are 
needed in order to elucidate the role of those factors further and account for their possible 
synergy. 
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Table 1: Characteristics of the cases and controls 
 Cases 
(ca) 
n = 209 
(%) 
Controls (co) 
n = 1681 (%) 
Co/Ca)
 ratio p 
Histological subtypes       
Embryonal tumors (including PNET) 100 (48)     
Ependymomas 33 (16)     
Astrocytomas 26 (12)     
Other gliomas 45 (21)     
Other specified tumors 5 (3)     
Gender      ns(b)
Male 125 (60) 932 (55)    
Age at the reference date (years)   0.03(b)
< 2  34 (16) 369 (22) 10.5  
2  15 (7) 153 (9) 10.2  
3  17 (8) 166 (10) 9.8  
4  25 (12) 145 (9) 5.6  
5-6  34 (16) 228 (14) 6.5  
7-8  33 (16) 163 (10) 4.8  
9-11  27 (13) 225 (13) 8.3  
12-14 24 (11) 232 (14) 9.7  
Countries of birth of the 4 grand-parents ns(c)
Europe 149 (71) 1209 (72)   
Africa / the Caribbean 5 (2) 34 (2)   
Asia 0 (0) 5 (0.3)   
North Africa 7 (3) 59 (4)   
Mixed 34 (16) 216 (13)   
missing data (at least one grand-parent) 14 (7) 158 (9)   
Paternal educational level  ns(c)
 ≤ High school 126 (61) 1063 (63)   
 > High school 79 (39) 601 (36)   
 missing data 4 (1) 17 (1)   
Maternal educational level  ns(c)
≤ High school 125 (60) 979 (58)   
> High school 84 (40) 701 (42)   
Socioeconomic categories ns(c)
Intellectual and scientific jobs, 
intermediate profession 92 (44) 713 (42)  
Administrative employees and sales 
workers 51 (24) 477 (28)  
 
Service workers 29 (13) 215 (13)   
Farmers, agricultural, craftsmen and 
factory workers 37 (18) 274 (16)  
 
(b) Chi square test 




Table 2: Parental smoking and childhood central nervous system tumours 
 Cases Controls 
 n = 209 (%) n = 1681 (%) OR
a 95% CIb
Maternal smoking (pregnancy)     
 No  165 (79)  1356 (81) 1.0 reference 
 Yes  44 (21)  325 (19) 1.1 [0.8-1.6] 
  < 10 cig/day  29 (9)  220 (13) 1.1 [0.7-1.6] 
  ≥ 10 cig/day  13 (6)  99 (6) 1.1 [0.6-2.0] 
 p for trend     ns 
Paternal smoking (year prior to birth) 
 No  101 (50)  897 (55) 1.0 reference 
 Yes  103 (50)  746 (45) 1.2 [0.9-1.6] 
  < 20 cig/day  52 (25)  426 (26) 1.1 [0.8-1.6] 
  ≥ 20 cig/day  51 (25)  310 (19) 1.4 [1.0-2.1] 
 p for trend     0.04 
Parental smoking      
 None  87 (43)  815 (50) 1.0 reference 
 Mother only  14 (7)  82 (5) 1.6 [0.9-3.0] 
 Father only  74 (36)  516 (31) 1.3 [1.0-1.9] 
 Both parents  29 (14)  230 (14) 1.2 [0.7-1.8] 
a OR: Odds Ratios adjusted for age and gender, b 95% CI: 95% Confidence Interval 
Table 3: Parental smoking by histological subgroup of central nervous system tumour 
 Controls
 n = 1681
PNET 
n = 100 
Ependymomas 
n = 33 
Astrocytomas 
n = 26 
Other gliomas 
n = 45 
  n OR 95% CI n OR 95% CI n OR 95% CI n OR 95% CI 
Maternal smoking (pregnancy)              
 No  1356  79 1.0 reference  27 1.0 reference  20 1.0 reference  35 1.0 reference
 Yes  325  21 1.1 [0.7-1.8]  6 1.0 [0.4-2.4]  6 1.3 [0.5-3.2]  10 1.2 [0.6-2.4] 
  < 10 cig/day  220  16 1.2 [0.7-2.1]  4 0.9 [0.3-2.7]  4 1.3 [0.4-3.8]  5 0.9 [0.3-2.3] 
  ≥ 10 cig/day  99  5 0.9 [0.3-2.2]  1 0.6 [0.1-4.3]  2 1.4 [0.3-5.9]  4 1.6 [0.5-4.5] 
 p for trend    ns   ns   ns   ns 
Paternal smoking (year prior to birth) 
 No  897  50 1.0 reference  14 1.0 reference  7 1.0 reference  26 1.0 reference
 Yes  746  49 1.2 [0.8-1.8]  18 1.6 [0.8-3.3]  18 3.1 [1.3-7.6]  17 0.8 [0.4-1.4] 
  < 20 cig/day  426  27 1.2 [0.7-1.9]  7 1.0 [0.4-2.6]  10 3.1 [1.2-8.4]  8 0.7 [0.3-1.5] 
  ≥ 20 cig/day  310  22 1.2 [0.7-2.1]  11 2.6 [1.2-5.9]  8 3.2 [1.2-9.1]  9 0.9 [0.4-2.0] 
 p for trend    ns   0.02   0.02   ns 
a OR: Odds Ratios adjusted for age and gender, b 95% CI: 95% Confidence Interval 
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Table 4: Maternal coffee and tea consumption during pregnancy and central nervous system tumours 
 Controls
 n = 1681 
All CNS Tumours 
n = 209 
PNET 
n = 100 
Ependymomas 
n = 33 
Astrocytomas 
n = 26 
Other gliomas 
n = 45 
  n OR 95%  CI n OR 95%  CI n OR 95%  CI n OR 95%  CI n OR 95% CI 
Co  ffee                 
No  639  76 1.0 reference  37 1.0 reference  11 1.0 reference  11 1.0 reference  15 1.0 reference 
Yes  1042  133 1.0 [0.8-1.4]  63 1.0 [0.6-1.5]  22 1.3 [0.6-2.8]  15 0.8 [0.4-1.7]  30 1.1 [0.6-2.1] 
 ≤ 3 cups/day  923  113 1.0 [0.7-1.3]  57 1.0 [0.6-1.5]  17 1.2 [0.5-2.5]  13 0.8 [0.3-1.8]  23 1.0 [0.5-1.9] 
 > 3 cups/day  119  20 1.4 [0.8-2.4]  6 0.9 [0.4-2.2]  5 2.7 [0.9-8.1]  2 0.9 [0.4-2.2]  7 2.3 [0.9-5.9] 
Tea                 
No  962  108 1.0 reference  54 1.0 reference  15 1.0 reference  14 1.0 reference  24 1.0 reference 
Yes  719  101 1.3 [0.9-1.7]  46 1.1 [0.8-1.7]  18 1.6 [0.8-3.1]  12 1.2 [0.5-2.5]  21 1.2 [0.6-2.1] 
 ≤ 1 cup/day  491  66 1.2 [0.9-1.7]  28 1.0 [0.6-1.7]  9 1.1 [0.5-2.6]  8 1.1 [0.5-2.7]  17 1.4 [0.7-2.9] 
 > 1 cup/day  228  35 1.4 [0.9-2.1]  18 1.4 [0.8-2.4]  9 2.5 [1.1-5.9]  4 1.2 [0.4-3.8]  4 0.7 [0.2-2.0] 
Coffee and tea (cups/day) 
None  353  37 1.0 reference  19 1.0 reference  4 1.0 reference  4 1.0 reference  10 1.0 reference 
Coffee ≤ 3 and tea ≤ 1  919  112 1.2 [0.8-1.7]  51 1.0 [0.6-1.7]  18 1.8 [0.6-5.4]  17 1.7 [0.6-5.0]  22 0.8 [0.4-1.7] 
Coffee > 3 and tea ≤ 1  104  15 1.4 [0.7-2.6]  5 0.9 [0.3-2.6]  2 1.9 [0.3- 10]  1 0.8 [0.1-7.1]  7 2.2 [0.8-6.0] 
Coffee ≤ 3 and tea > 1  210  28 1.3 [0.7-2.1]  15 1.3 [0.6-2.6]  6 2.6 [0.7-9.5]  3 1.3 [0.3-5.8]  4 0.6 [0.2-2.0] 
Coffee > 3 and tea > 1  12  5 4.4 [1.5- 13]  1 1.8 [0.2- 14]  3 23.1 [4.4-120]  1 8.5 [0.9- 84]  0 - - 




Table 5: Maternal alcohol consumption during pregnancy and central nervous system tumours 
 Controls 
 n = 1681 
All CNS Tumours 
n = 209 
PNET 
n = 100 
Ependymomas 
n = 33 
Astrocytomas 
n = 26 
Other Gliomas 
n = 45 
  n OR 95% CI n OR 95% CI n OR 95% CI n OR 95% CI n OR 95% CI 
Any alcohol                 
No  1065  134 1.0 reference  60 1.0 reference  22 1.0 reference  18 1.0 reference  30 1.0 reference 
Yes  616  75 0.9 [0.7-1.3]  40 1.1 [0.7-1.7]  11 0.9 [0.4-2.0]  8 0.8 [0.3-1.8]  15 0.8 [0.4-1.5] 
 < 1 glass/week  285  39 1.1 [0.7-1.6]  25 1.5 [0.9-2.4]  5 0.9 [0.3-2.3]  3 0.6 [0.2-2.2]  6 0.7 [0.3-1.7] 
 1 glass/week  136  14 0.8 [0.4-1.4]  8 1.0 [0.4-2.1]  2 0.8 [0.2-3.6]  1 0.4 [0.1-3.2]  2 0.5 [0.1-2.0] 
 2 glasses/week  70  9 1.0 [0.5-2.1]  2 0.5 [0.1-2.2]  1 0.8 [0.1-5.8]  2 1.7 [0.4-7.5]  4 2.0 [0.7-5.8] 
 ≥ 3 glasses/week  125  13 0.8 [0.7-1.6]  5 0.7 [0.3-1.7]  3 1.3 [0.4-4.5]  2 1.0 [0.2-4.3]  3 0.8 [0.2-2.6] 
Wine                 
No  1241  159 1.0 reference  74 1.0 reference  27 1.0 reference  20 1.0 reference  34 1.0 reference 
Yes  440  50 0.9 [0.6-1.2]  26 0.9 [0.6-1.5]  6 0.7 [0.3-1.6]  6 0.9 [0.3-2.2]  11 0.9 [0.4-1.7] 
Beer / cider                 
No  1474  177 1.0 reference  83 1.0 reference  31 1.0 reference  23 1.0 reference  36 1.0 reference 
Yes  207  32 1.3 [0.8-1.9]  17 1.4 [0.8-2.5]  2 0.5 [0.1-2.0]  3 1.0 [0.3-3.2]  9 1.7 [0.8-3.6] 
Spirits                 
No  1411  181 1.0 reference  82 1.0 reference  27 1.0 reference  26 1.0 reference  42 1.0 reference 
Yes  270  28 0.8 [0.5-1.2]  18 1.1 [0.6-1.9]  6 1.3 [0.5-3.2]  0 - -  3 0.3 [0.1-1.1] 
                 
No alcohol  1065  134 1.0 reference  60 1.0 reference  22 1.0 reference  18 1.0 reference  30 1.0 reference 
Wine only  201  24 0.9 [0.6-1.5]  10 0.8 [0.4-1.7]  3 0.8 0.4-2.6]  5 1.5 [0.5-4.2]  6 1.0 [0.4-2.5] 
Beer/cider only  65  10 1.3 [0.6-2.5]  3 0.8 [0.3-2.8]  2 1.5 [0.4-6.8]  2 2.0 [0.4-6.8]  3 1.7 [0.5-5.7] 
Spirits only  95  11 0.9 [0.5-1.7]  8 1.4 [0.6-3.0]  3 1.6 [0.5-5.7]  0 - -  0 - - 
Wine and beer/cider  80  13 1.2 [0.7-2.3]  9 1.8 [0.9-3.9]  0 - -  1 0.8 [0.1-5.9]  3 1.2 [0.4-4.1] 
Wine and spirits  113  8 0.6 [0.3-1.2]  5 0.8 [0.3-1.9]  3 1.5 [0.4-5.0]  0 - -  0 - - 
Beer/cider and spirits  16  4 2.0 [0.7-6.2]  3 3.4 [0.9- 12]  0 - -  0 - -  1 2.0 [0.3- 16] 
Wine, beer/cider and spirits  46  5 0.8 [0.3-2.1]  2 0.7 [0.2-3.0]  0 - -  0 - -  2 1.3 [0.3-5.7] 
a OR: Odds Ratios adjusted for age and gender, b 95% CI: 95% Confidence Interval
 
Appendix 
SFCE Investigators Hospital City (France) 
Olivier Hartmann  Institut Gustave Roussy Villejuif 
Jacques Grill  Institut Gustave Roussy Villejuif 
Christophe Bergeron  Centre Léon Bérard Lyon 
Didier Frappaz  Centre Léon Bérard Lyon 
Jean Michon  Institut Curie Paris 
François Doz  Institut Curie Paris 
Hervé Rubie  Hôpital des Enfants Toulouse 
Anne-Isabelle Bertozzi  Hôpital des Enfants Toulouse 
Alain Pierre-Kahn  Enfants Malades Paris 
Anne-Sophie 
Defachelles  
Centre Oscar Lambret Lille 
Dominique Plantaz  CHU – La Tronche Grenoble 
Anne Pagnier CHU – La Tronche Grenoble 
Jean-Pierre Vannier  Charles Nicolle Rouen 
Xavier Rialland  CHU Angers 
Pierre Bordigoni  CHU Nancy 
Danièle Sommelet  CHU Nancy 
Jean-Pierre Lamagnere  Centre Gatien de Clocheville Tours 
Claire Berger  CHU Saint-Etienne 
Yves Perel  Pellegrin Tripode Bordeaux 
Céline Icher  Pellegrin Tripode Bordeaux 
Patrick Lutz  Hôpital de Hautepierre Strasbourg 
Virginie Gandemer  CHU – Hôpital Sud Rennes 
Christian Berthou CHU Brest 
Jean-Louis Bernard  La Timone Marseille 
Jean-Claude Gentet  La Timone  Marseille 
François Demeocq  Hôtel-Dieu Clermont-Ferrand 
Françoise Mechinaud  Hôpital Mère et Enfants Nantes 
Geneviève Margueritte  Arnaud de Villeneuve Montpellier 
Lionel De Lumley  CHRU Limoges 
Brigitte Pautard  CHU Amiens 
Nicolas Sirvent  L’Archet Nice 
Patrick Boutard  CHRU Caen 
Frédéric Millot  CHU Jean Bernard Poitiers 
Françoise Lapierre  CHU Jean Bernard Poitiers-neuro 
Emmanuel Plouvier  CHR Besançon 
Catherine Behar  American Memorial Hospital Reims 
André Baruchel  Saint-Louis / Robert debré  Paris 
Yves Bertrand  Debrousse Lyon 
Gérard Couillault  Hôpital d’Enfants Dijon 
Alain Fischer  Hôpital des Enfants Malades Paris 
Guy Leverger  Trousseau Paris 
Brigitte Nelken  Jeanne de Flandre Lille 
Alain Robert  Hôpital des Enfants Toulouse 
Christine Soler  Fondation Lenval Nice 
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